Showing results (111-120 of 216) with videos related to

Sort By:
Pageof 22
European Journal of Haematology|April 11, 2007
Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in ChinaZeping Zhou, Li Yang, Zhenping Chen, et al.
International Journal of Hematology|November 13, 2008
Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from ChinaJie Bai, Yangping Xue, Lei Ye, et al.
Autoimmunity|July 15, 2014
The defective bone marrow-derived mesenchymal stem cells in patients with chronic immune thrombocytopeniaDonglei Zhang, Huiyuan Li, Li Ma, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 21, 2020
Real-world analysis of haemophilia patients in China: A single centre's experienceXuewen Song, Wei Liu, Feng Xue, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 24, 2021
Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophiliaRichard Huan Xu, Dong Dong, Nan Luo, et al.
Advances in Therapy|June 4, 2025
Disease Burden and Treatment Patterns Amongst Patients with Haemophilia A in China: A Retrospective Database Analysis StudyXuewen Song, Feng Xue, Lingling Chen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 27, 2020
An overview of patients with haemophilia A in China: Epidemiology, disease severity and treatment strategiesXuewen Song, Jia Zhong, Feng Xue, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 13, 2025
The efficacy, safety, and pharmacokinetics of N8-GP in previously treated Chinese patients with haemophilia A: results from the phase 3b pathfinder10 studyRunhui Wu, Yun Chen, Wenqian Li, et al.
Research and Practice in Thrombosis and Haemostasis|March 14, 2022
Prophylactic emicizumab for hemophilia A in the Asia-Pacific region: A randomized study (HAVEN 5)Renchi Yang, Shujie Wang, Xuefeng Wang, et al.
Haematologica|June 12, 2025
First-in-human pharmacokinetic, safety, and preliminary efficacy of single- and multiple-dose FRSW117, a novel PEGylated recombinant factor VIII-Fc fusion protein with an extended half-life, in patients with severe hemophilia AFeng Xue, Shuxia Guo, Ping Liu, et al.
Pageof 22